The Utility of Trial and Error

The Neglect of Experiment. Allan Franklin. Cambridge University Press, New York, 1986. 290 pp., illus. $42.50. A physicist-turned-philosopher, Allan Franklin is interested in experiment. The "neglect" of his title attaches to his new discipline. Philosophers and historians have traditionally taken the nature and role of scientific experiment for granted. Only recently have a few students of science, Franklin among them, seriously begun to examine experimentation. This book collects his essays, a

Written byAndy Pickering
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At the heart of the book are historical studies of four sets of experiments in modem physics: Millikan's oildrop experiments, which established the quantization and magnitude of the charge on the electron; the experiments that in 1964 and 1965 established the CP (charge-parity) noninvariance of the decays of K particles; the 1957 experiments that established the nonconservation of parity; and the measurements made between 1928 and 1930 by R.T. Cox and Carl T. Chase, which might have also established the nonconservation of parity but didn't.

The traditional neglect of experiment is legitimized by the assumption that experimentation is somehow trivial and unproblematic, that scientists just set up their apparatus according to principles laid down in advance, and that incontestable facts simply pop out. Franklin's studies expose the naiveté of this view. They exemplify the complexity and uncertainty, the space for doubt, inherent in the performance and interpretation of experiments. They ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies